• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-492通过抑制SOX7表达促进人乳腺癌细胞的增殖和细胞周期。

MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.

作者信息

Shen Fei, Cai Wen-Song, Feng Zhe, Li Jiang-Lin, Chen Ji-Wei, Cao Jie, Xu Bo

机构信息

Department of General Surgery, Guangzhou First People's Hospital, Guangzhou Medical University, 1 Panfu Road, Yuexiu District, Guangzhou, 510180, People's Republic of China.

出版信息

Tumour Biol. 2015 Mar;36(3):1913-21. doi: 10.1007/s13277-014-2794-z. Epub 2014 Nov 19.

DOI:10.1007/s13277-014-2794-z
PMID:25407488
Abstract

MicroRNAs (miRNAs) have emerged as important regulators that potentially play critical roles in cancer cell biological processes. Previous studies have shown that miR-492 plays an important role in cell tumorigenesis in multiple kinds of human cancer cells. However, the underlying mechanisms of this microRNA in breast cancer remain largely unknown. In the present study, we investigated miR-492's role in cell proliferation of breast cancer. MiR-492 expression was markedly upregulated in breast cancer tissues and breast cancer cells. Overexpression of miR-492 promoted the proliferation and anchorage-independent growth of breast cancer cells. Bioinformatics analysis further revealed sex-determining region Y-box 7 (SOX7), a putative tumor suppressor, as a potential target of miR-492. Data from luciferase reporter assays showed that miR-492 directly binds to the 3'-untranslated region (3'-UTR) of SOX7 messenger RNA (mRNA) and repressed expression at both transcriptional and translational levels. Ectopic expression of miR-492 led to downregulation of SOX7 protein, which resulted in the upregulation of cyclin D1 and c-Myc. In functional assays, SOX7 silenced in miR-492-in-transfected ZR-75-30 cells has positive effect to promote cell proliferation, suggesting that direct SOX7 downregulation is required for miR-492-induced cell proliferation and cell cycle of breast cancer. In sum, these results suggest that miR-492 represents a potential onco-miR and participates in breast cancer carcinogenesis by suppressing SOX7 expression.

摘要

微小RNA(miRNA)已成为重要的调节因子,可能在癌细胞生物学过程中发挥关键作用。先前的研究表明,miR-492在多种人类癌细胞的细胞肿瘤发生中起重要作用。然而,这种微小RNA在乳腺癌中的潜在机制仍 largely unknown。在本研究中,我们调查了miR-492在乳腺癌细胞增殖中的作用。miR-492在乳腺癌组织和乳腺癌细胞中明显上调。miR-492的过表达促进了乳腺癌细胞的增殖和非锚定依赖性生长。生物信息学分析进一步揭示了性别决定区Y盒7(SOX7),一种假定的肿瘤抑制因子,是miR-492的潜在靶点。荧光素酶报告基因检测数据表明,miR-492直接与SOX7信使核糖核酸(mRNA)的3'-非翻译区(3'-UTR)结合,并在转录和翻译水平上抑制其表达。miR-492的异位表达导致SOX7蛋白下调,进而导致细胞周期蛋白D1和c-Myc上调。在功能试验中,在miR-492转染的ZR-75-30细胞中沉默SOX7对促进细胞增殖有积极作用,表明直接下调SOX7是miR-492诱导乳腺癌细胞增殖和细胞周期所必需的。总之,这些结果表明,miR-492是一种潜在的致癌miRNA,通过抑制SOX7表达参与乳腺癌的发生。

相似文献

1
MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.微小RNA-492通过抑制SOX7表达促进人乳腺癌细胞的增殖和细胞周期。
Tumour Biol. 2015 Mar;36(3):1913-21. doi: 10.1007/s13277-014-2794-z. Epub 2014 Nov 19.
2
MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression.miR-32 通过抑制 PHLPP2 的表达促进人乳腺癌细胞的增殖。
Biomed Pharmacother. 2015 Oct;75:105-10. doi: 10.1016/j.biopha.2015.07.037. Epub 2015 Aug 12.
3
miR-935 promotes gastric cancer cell proliferation by targeting SOX7.微小RNA-935通过靶向SOX7促进胃癌细胞增殖。
Biomed Pharmacother. 2016 Apr;79:153-8. doi: 10.1016/j.biopha.2016.01.011. Epub 2016 Feb 22.
4
miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7.微小RNA-935通过靶向SOX7促进肝癌细胞增殖和迁移。
Oncol Res. 2017 Mar 13;25(3):427-435. doi: 10.3727/096504016X14747300207374. Epub 2016 Sep 30.
5
Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.miR-664的过表达通过靶向SOX7与骨肉瘤细胞迁移和侵袭能力增强相关。
Clin Exp Med. 2017 Feb;17(1):51-58. doi: 10.1007/s10238-015-0398-6. Epub 2015 Oct 29.
6
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.孕激素介导的致癌信号下调肿瘤抑制 miR-16 促进乳腺癌发生。
Breast Cancer Res. 2012 May 14;14(3):R77. doi: 10.1186/bcr3187.
7
MiR-595 targeting regulation of SOX7 expression promoted cell proliferation of human glioblastoma.miR-595 通过靶向调控 SOX7 的表达促进人脑胶质瘤细胞的增殖。
Biomed Pharmacother. 2016 May;80:121-126. doi: 10.1016/j.biopha.2016.03.008. Epub 2016 Mar 19.
8
Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma.Mir-184在转录后水平调控SOX7的表达,并促进人肝癌细胞的增殖。
PLoS One. 2014 Feb 18;9(2):e88796. doi: 10.1371/journal.pone.0088796. eCollection 2014.
9
MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.微小RNA-494-3p通过靶向Sox7促进鼻咽癌细胞的生长、迁移和侵袭。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809993. doi: 10.1177/1533033818809993.
10
miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.在乳腺癌中上调的miR-135b通过调节LATS2促进细胞生长并扰乱细胞周期。
Int J Oncol. 2016 May;48(5):1997-2006. doi: 10.3892/ijo.2016.3405. Epub 2016 Feb 22.

引用本文的文献

1
The miR-1305/KLF5 negative regulatory loop affects pancreatic cancer cell proliferation and apoptosis.微小RNA-1305/ Krüppel样因子5负调控环影响胰腺癌细胞的增殖和凋亡。
Hum Cell. 2025 Feb 8;38(2):51. doi: 10.1007/s13577-025-01173-3.
2
Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies.绘制微小RNA的功能,其作为乳腺癌中肿瘤-免疫细胞通讯的关键调节因子及潜在治疗策略。
Front Cell Dev Biol. 2024 Apr 25;12:1390704. doi: 10.3389/fcell.2024.1390704. eCollection 2024.
3
Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer.

本文引用的文献

1
MiRNA-15a mediates cell cycle arrest and potentiates apoptosis in breast cancer cells by targeting synuclein-γ.微小RNA-15a通过靶向突触核蛋白-γ介导乳腺癌细胞的细胞周期阻滞并增强其凋亡。
Asian Pac J Cancer Prev. 2014;15(16):6949-54. doi: 10.7314/apjcp.2014.15.16.6949.
2
MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.微小RNA-18a抑制基底样乳腺癌中缺氧诱导因子1α的活性及肺转移。
Breast Cancer Res. 2014 Jul 28;16(4):R78. doi: 10.1186/bcr3693.
3
Retinoblastoma protein and MyoD function together to effect the repression of Fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis.
miRNAs 在乳腺癌治疗毒性的调控和生物标志物中的生物学意义
Int J Mol Sci. 2023 Aug 11;24(16):12694. doi: 10.3390/ijms241612694.
4
MicroRNAs as Potential Biomarkers in Gynecological Cancers.微小RNA作为妇科癌症的潜在生物标志物
Biomedicines. 2023 Jun 13;11(6):1704. doi: 10.3390/biomedicines11061704.
5
Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epithelium.miR-183-5p 或 miR-492 的过表达会触发非肿瘤性乳腺上皮的侵袭和增殖以及极性丧失。
Sci Rep. 2022 Dec 20;12(1):21974. doi: 10.1038/s41598-022-25663-8.
6
Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer.血清中循环微小RNA作为非小细胞肺癌早期诊断的生物标志物
Front Genet. 2021 Jul 9;12:673926. doi: 10.3389/fgene.2021.673926. eCollection 2021.
7
Human milk extracellular vesicle miRNA expression and associations with maternal characteristics in a population-based cohort from the Faroe Islands.法罗群岛人群队列的母乳细胞外囊泡 miRNA 表达及其与母体特征的关联。
Sci Rep. 2021 Mar 12;11(1):5840. doi: 10.1038/s41598-021-84809-2.
8
Metapristone (RU486-derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axis.米非司酮(RU486衍生物)通过调节miR-492/Klf5/Nrf1轴抑制子宫内膜癌细胞进展。
Cancer Cell Int. 2021 Jan 7;21(1):29. doi: 10.1186/s12935-020-01682-1.
9
Association between rs2289030 G>C and susceptibility to Hirschsprung disease in southern Chinese children.rs2289030 G>C 与中国南方儿童先天性巨结肠病易感性的相关性研究。
J Int Med Res. 2020 Oct;48(10):300060520961680. doi: 10.1177/0300060520961680.
10
Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer.连接缺失的环节:非编码RNA作为乳腺癌治疗敏感性的关键调节因子
Cancers (Basel). 2020 Sep 21;12(9):2698. doi: 10.3390/cancers12092698.
视网膜母细胞瘤蛋白和肌分化抗原(MyoD)共同发挥作用,在与肌生成相关的终末细胞周期停滞过程中抑制Fra-1,进而抑制细胞周期蛋白D1。
J Biol Chem. 2014 Aug 22;289(34):23417-27. doi: 10.1074/jbc.M113.532572. Epub 2014 Jul 8.
4
The role of microRNAs in human breast cancer progression.微小RNA在人类乳腺癌进展中的作用。
Tumour Biol. 2014 Jul;35(7):6235-44. doi: 10.1007/s13277-014-2202-8. Epub 2014 Jun 18.
5
Curcumin suppresses cell proliferation through inhibition of the Wnt/β-catenin signaling pathway in medulloblastoma.姜黄素通过抑制髓母细胞瘤中的Wnt/β-连环蛋白信号通路来抑制细胞增殖。
Oncol Rep. 2014 Jul;32(1):173-80. doi: 10.3892/or.2014.3206. Epub 2014 May 22.
6
Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.Sox7 表达降低与 Wnt/β-catenin 信号通路的上调以及胃癌患者的不良生存相关。
Int J Mol Med. 2014 Jul;34(1):197-204. doi: 10.3892/ijmm.2014.1759. Epub 2014 Apr 25.
7
Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma.Mir-184在转录后水平调控SOX7的表达,并促进人肝癌细胞的增殖。
PLoS One. 2014 Feb 18;9(2):e88796. doi: 10.1371/journal.pone.0088796. eCollection 2014.
8
MicroRNAs - a new generation molecular targets for treating cellular diseases.MicroRNAs - 新一代治疗细胞疾病的分子靶标。
Theranostics. 2013 Dec 18;3(12):927-9. doi: 10.7150/thno.8113. eCollection 2013.
9
MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer.MUC4 诱导β-catenin 的核转位:胰腺癌生长、转移和血管生成的新机制。
Cancer Lett. 2014 Apr 28;346(1):104-13. doi: 10.1016/j.canlet.2013.12.021. Epub 2013 Dec 25.
10
SOX7: from a developmental regulator to an emerging tumor suppressor.SOX7:从发育调控因子到新兴的肿瘤抑制因子。
Histol Histopathol. 2014 Apr;29(4):439-45. doi: 10.14670/HH-29.10.439. Epub 2013 Nov 29.